STOCK TITAN

SenesTech to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences earnings clinical trial

SenesTech (NASDAQ: SNES) will report third quarter 2025 financial results for the period ended September 30, 2025 after the market close on Monday, November 10, 2025.

The company will host a conference call the same day at 5:00 p.m. Eastern time to review results. Interested parties can access the live webcast via the Investor Relations section of the company website at https://app.webinar.net/Pj7rLgb3Ew4 or http://senestech.investorroom.com/. A webcast replay will be available on the Investor Relations site for 90 days.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 2 Alerts

-0.90% News Effect
+10.9% Peak Tracked
-$148K Valuation Impact
$16M Market Cap
0.4x Rel. Volume

On the day this news was published, SNES declined 0.90%, reflecting a mild negative market reaction. Argus tracked a peak move of +10.9% during that session. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $148K from the company's valuation, bringing the market cap to $16M at that time.

Data tracked by StockTitan Argus on the day of publication.

Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time

PHOENIX, Nov. 3, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for pest management, will report third quarter 2025 financial results for the period ended September 30, 2025, after the market close on Monday, November 10, 2025. The Company has scheduled a conference call that same day, Monday, November 10, 2025, at 5:00 p.m. Eastern time, to review the results.

Third Quarter 2025 Conference Call Details

Date and Time: Monday, November 10, 2025, at 5:00 p.m. Eastern time

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company's website at https://app.webinar.net/Pj7rLgb3Ew4 or http://senestech.investorroom.com/

Replay: A webcast replay will be available in the Investor Relations section of the Company's website at http://senestech.investorroom.com/ for 90 days.

About SenesTech
We are committed to improving the health of the world by humanely managing animal pest populations through our expertise in fertility control. We invented ContraPest®, the only U.S. EPA-registered contraceptive for male and female rats, as well as Evolve Rat and Evolve Mouse, EPA-designated minimum risk contraceptives for rodents, reflecting our mission to provide products that are proactive, safe and sustainable. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable.

For more information, visit https://senestech.com.

Safe Harbor Statement This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby.  Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases.  You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements.  Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; our ability to regain and maintain compliance with Nasdaq's continued listing requirements; and regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.  All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date.  Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

CONTACT: 
Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-third-quarter-2025-financial-results-on-monday-november-10-2025-302602768.html

SOURCE SenesTech, Inc.

FAQ

When will SenesTech (SNES) release third quarter 2025 results?

SenesTech will release Q3 2025 results after the market close on Monday, November 10, 2025.

What time is the SenesTech (SNES) Q3 2025 conference call?

The conference call is scheduled for Monday, November 10, 2025 at 5:00 p.m. Eastern time.

How can investors access the SenesTech (SNES) live webcast for Q3 2025 results?

Access the live webcast via the Investor Relations site at https://app.webinar.net/Pj7rLgb3Ew4 or http://senestech.investorroom.com/.

Will there be a replay of the SenesTech (SNES) Q3 2025 webcast and for how long?

Yes. A webcast replay will be available on the Investor Relations site for 90 days.

What period do SenesTech's third quarter 2025 results cover?

The results cover the period ended September 30, 2025.
Senestech Inc

NASDAQ:SNES

SNES Rankings

SNES Latest News

SNES Latest SEC Filings

SNES Stock Data

12.17M
5.00M
4.45%
2.5%
1.67%
Specialty Chemicals
Agricultural Chemicals
Link
United States
PHOENIX